Glucoryl-M 3 Forte Tablet PR is a combination oral antidiabetic medication containing Glimepiride 3mg and Metformin 1000mg, designed for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta cells to enhance insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production, improving peripheral glucose uptake, and enhancing insulin sensitivity. The combination of these two agents provides complementary mechanisms of action, offering effective glycemic control in patients inadequately managed by monotherapy. Glucoryl-M 3 Forte Tablet PR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. The prolonged-release formulation allows for sustained drug release, promoting better patient compliance and minimizing gastrointestinal side effects commonly associated with metformin. Contraindications include severe renal impairment, metabolic acidosis, and hypersensitivity to any component. Caution is advised in patients with hepatic dysfunction, cardiovascular disease, or conditions predisposing to hypoglycemia. Regular monitoring of blood glucose, renal function, and lactic acid levels is recommended during therapy. This combination therapy should be used under medical supervision to optimize dosage and minimize adverse effects.